business

Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference - CNBC

Novo Nordisk's CEO spoke about GLP-1 pricing and Pfizer's CEO spoke about the company's obesity ambitions while at the JPMorgan Healthcare Conference.

By:Annika Kim Constantino
Source:CNBC
Published:
Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference - CNBC
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Good mornin… [+5221 chars]

Related News